# The Clostridioides Difficile Trial of REC-3964

> **NCT06536465** · PHASE2 · TERMINATED · sponsor: **Recursion Pharmaceuticals Inc.** · enrollment: 3 (actual)

## Conditions studied

- Recurrent Clostridioides Difficile Infection

## Interventions

- **DRUG:** REC-3964

## Key facts

- **NCT ID:** NCT06536465
- **Lead sponsor:** Recursion Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-10-14
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-05-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study was terminated due to sponsor decision. This decision was not related to safety concerns.
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06536465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06536465, "The Clostridioides Difficile Trial of REC-3964". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06536465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*